ImmuCell Management
Management criteria checks 4/4
ImmuCell's CEO is Michael Brigham, appointed in Oct 1991, has a tenure of 32.58 years. total yearly compensation is $395.24K, comprised of 89.9% salary and 10.1% bonuses, including company stock and options. directly owns 2.76% of the company’s shares, worth €1.01M. The average tenure of the management team and the board of directors is 8.7 years and 6.3 years respectively.
Key information
Michael Brigham
Chief executive officer
US$395.2k
Total compensation
| CEO salary percentage | 89.9% |
| CEO tenure | 32.6yrs |
| CEO ownership | 2.8% |
| Management average tenure | 8.7yrs |
| Board average tenure | 6.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$395k | US$355k | -US$6m |
| Sep 30 2023 | n/a | n/a | -US$6m |
| Jun 30 2023 | n/a | n/a | -US$6m |
| Mar 31 2023 | n/a | n/a | -US$5m |
| Dec 31 2022 | US$600k | US$343k | -US$2m |
| Sep 30 2022 | n/a | n/a | -US$752k |
| Jun 30 2022 | n/a | n/a | US$51k |
| Mar 31 2022 | n/a | n/a | US$876k |
| Dec 31 2021 | US$360k | US$331k | -US$78k |
| Sep 30 2021 | n/a | n/a | US$36k |
| Jun 30 2021 | n/a | n/a | -US$434k |
| Mar 31 2021 | n/a | n/a | -US$1m |
| Dec 31 2020 | US$354k | US$325k | -US$1m |
| Sep 30 2020 | n/a | n/a | -US$2m |
| Jun 30 2020 | n/a | n/a | -US$2m |
| Mar 31 2020 | n/a | n/a | -US$2m |
| Dec 31 2019 | US$344k | US$315k | -US$1m |
| Sep 30 2019 | n/a | n/a | -US$2m |
| Jun 30 2019 | n/a | n/a | -US$2m |
| Mar 31 2019 | n/a | n/a | -US$2m |
| Dec 31 2018 | US$426k | US$309k | -US$2m |
| Sep 30 2018 | n/a | n/a | -US$1m |
| Jun 30 2018 | n/a | n/a | -US$2m |
| Mar 31 2018 | n/a | n/a | -US$974k |
| Dec 31 2017 | US$411k | US$299k | -US$168k |
Compensation vs Market: Michael's total compensation ($USD395.24K) is about average for companies of similar size in the German market ($USD399.70K).
Compensation vs Earnings: Michael's compensation has been consistent with company performance over the past year.
CEO
Michael Brigham (62 yo)
32.6yrs
Tenure
US$395,235
Compensation
Mr. Michael F. Brigham has been the Chief Executive Officer and President of Immucell Corporation since February 2000 and its Principal Financial Officer and Treasurer since October 1991. Mr. Brigham has b...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 32.6yrs | US$395.24k | 2.76% $ 1.0m | |
| VP of Sales & Marketing and Director | 9.3yrs | US$323.52k | 0.11% $ 39.8k | |
| Vice President of Manufacturing Operations | 8.1yrs | US$312.07k | 0% $ 0 | |
| Director of Finance & Administration and Controller | no data | no data | no data | |
| Senior Director of Quality | 5.8yrs | no data | no data | |
| Director of Product Development | no data | no data | no data |
8.7yrs
Average Tenure
62yo
Average Age
Experienced Management: IUL's management team is seasoned and experienced (8.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 25.2yrs | US$395.24k | 2.76% $ 1.0m | |
| VP of Sales & Marketing and Director | 6.3yrs | US$323.52k | 0.11% $ 39.8k | |
| Independent Director | 10.2yrs | US$30.00k | 0.080% $ 29.3k | |
| Independent Chairman of the Board | 17.4yrs | US$42.00k | 1.32% $ 484.1k | |
| Independent Director | 6.3yrs | US$30.00k | 0% $ 0 | |
| Independent Director | 3.9yrs | US$28.00k | 0% $ 0 | |
| Independent Director | less than a year | US$51.30k | no data |
6.3yrs
Average Tenure
58yo
Average Age
Experienced Board: IUL's board of directors are considered experienced (6.3 years average tenure).